Prevalence of Systolic Impairment in an Unselected Regional Population With Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 98, Issue 9, 2006, Pages 1269-1272

  Efthimiadis, Georgios K ^a   Giannakoulas, Georgios ^a   Parharidou, Despina G ^a   Karvounis, Haralampos I ^a   Mochlas, Soterios T ^a   Styliadis, Ioannis H ^a   Gavrielides, Stavros ^a   Gemitzis, Konstantinos D ^a   Giannoglou, Georgios D ^a   Parharidis, Georgios E ^a   Louridas, Georgios E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; HEART ARREST; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33750081109     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.05.063     Document Type: Article

References (18)

1. ten Cate F.J., and Roelandt J. Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J 97 (1979) 762-765
2. Spirito P., Maron B.J., Bonow R.O., and Epstein S.E. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 60 (1987) 123-129
3. Hecht G.M., Klues H.G., Roberts W.C., and Maron B.J. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 22 (1993) 489-497
4. Ko Y.L., Lin J.L., Lei M.H., Chen J.J., Tsou S.S., Kuan P., and Lien W.P. Apical segmental dysfunction in hypertrophic cardiomyopathy: progression into end-stage heart failure with sudden cardiac death. Cardiology 86 (1995) 436-440
5. Ko Y.L., Chen J.J., Tang T.K., Cheng J.J., Lin S.Y., Liou Y.C., Kuan P., Wu C.W., Lien W.P., and Liew C.C. Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg→Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure. Hum Genet 97 (1996) 585-590
6. Arbustini E., Fasani R., Morbini P., Diegoli M., Grasso M., Dal Bello B., Marangoni E., Banfi P., Banchieri N., Bellini O., et al. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart 80 (1998) 548-558
7. Konno T., Shimizu M., Ino H., Fujino N., Uchiyama K., Mabuchi T., Sakata K., Kaneda T., Fujita T., Masuta E., and Mabuchi H. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death. Clin Sci 110 (2005) 125-131
8. Kubo T., Kitaoka H., Okawa M., Matsumura Y., Hitomi N., Yamasaki N., Furuno T., Takata J., Nishinaga M., Kimura A., and Doi Y.L. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese. J Am Coll Cardiol 46 (2005) 1737-1743
9. Thaman R., Gimeno J.R., Reith S., Esteban M.T., Limongelli G., Murphy R.T., Mist B., McKenna W.J., and Elliott P.M. Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy. J Am Coll Cardiol 44 (2004) 398-405
10. Thaman R., Gimeno J.R., Murphy R.T., Kubo T., Sachdev B., Mogensen J., Elliott P.M., and McKenna W.J. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart 91 (2005) 920-925
11. Biagini E., Coccolo F., Ferlito M., Perugini E., Rocchi G., Bacchi-Reggiani L., Lofiego C., Boriani G., Prandstraller D., Picchio F.M., et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 46 (2005) 1543-1550
12. Maron B.J., Bonow R.O., Cannon III R.O., Leon M.B., and Epstein S.E. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316 (1987) 780-789
13. Maron B.J., Gottdiener J.S., and Epstein S.E. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 48 (1981) 418-428
14. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
15. Panza J.A., Petrone R.K., Fananapazir L., and Maron B.J. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 19 (1992) 91-99
16. Maron B.J., and Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 81 (1998) 1339-1344
17. Ino T., Nishimoto K., Okubo M., Akimoto K., Yabuta K., Kawai S., Okada R., and Sueyoshi N. Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy. Am J Cardiol 79 (1997) 1137-1141
18. Varnava A.M., Elliott P.M., Sharma S., McKenna W.J., and Davies M.J. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84 (2000) 476-482